Clinical trial
Belatacept Therapy for the Failing Renal Allograft
NCT01921218 is registered in ClinicalTrials.gov with Andrew B Adams as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Belatacept Therapy for the Failing Renal Allograft
- Lead sponsor
- Andrew B Adams
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- December 12, 2019
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
failing renal allograft